• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型强心磷酸二酯酶抑制剂1,2 - 二氢 - 5 - 咪唑并[1,2 - a]吡啶 - 6 - 基 - 6 - 甲基 - 2 - 氧代 - 3 - 吡啶甲腈盐酸盐一水合物对主动脉输入阻抗的影响

Effects of the new cardiotonic phosphodiesterase inhibitor 1,2-dihydro-5- imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-3-pyridine-carbonitrile hydrochloride monohydrate on aortic input impedance.

作者信息

Kubota T, Itaya R, Todaka K, Sugimachi M, Sunagawa K, Takeshita A

机构信息

Research Institute of Angiocardiology and Cardiovascular Clinic, Kyushu University, Fukuoka, Japan.

出版信息

Arzneimittelforschung. 1991 Dec;41(12):1211-5.

PMID:1815518
Abstract

Beneficial effects of cardiotonic phosphodiesterase inhibitors on congestive heart failure are possibly mediated in part by a reduction of afterload. 1,2-Dihydro-5-imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-3- pyridinecarbonitrile hydrochloride monohydrate (E-1020, CAS 119615-63-3), a new cardiotonic phosphodiesterase inhibitor was evaluated for its effect on aortic input impedance in eight anesthetized open-chest dogs. First instantaneous aortic pressure and flow under random ventricular pacing before and after E-1020 infusions (10, 30, and 100 micrograms/kg i.v.) were measured. Then aortic input impedance over the frequency range of 0.024 to 20 Hz was estimated using a multichannel autoregressive model. With the infusion of E-1020, aortic input impedance was decreased in the low frequency range (below 0.1 Hz) and shifted leftward in the transitional frequency range (from 0.1 to 2 Hz), while it remained unchanged in the high frequency range (above 2 Hz). Parameterization of the aortic input impedance using a three-element Windkessel model indicated that E-1020 (at a dose of 100 micrograms/kg i.v.) decreased arterial resistance by 35% (p less than 0.01) and increased arterial compliance by 12% (p less than 0.01). It is concluded that E-1020 improves cardiac performance by unloading static and dynamic afterload in addition to its cardiotonic effect.

摘要

强心磷酸二酯酶抑制剂对充血性心力衰竭的有益作用可能部分是通过降低后负荷介导的。对一种新型强心磷酸二酯酶抑制剂1,2 -二氢-5-咪唑并[1,2 - a]吡啶-6-基-6-甲基-2-氧代-3-吡啶甲腈盐酸盐一水合物(E - 1020,CAS 119615 - 63 - 3)在八只麻醉开胸犬中评估了其对主动脉输入阻抗的影响。首先测量了E - 1020静脉输注(10、30和100微克/千克)前后随机心室起搏时的瞬时主动脉压力和流量。然后使用多通道自回归模型估计0.024至20 Hz频率范围内的主动脉输入阻抗。随着E - 1020的输注,低频范围(低于0.1 Hz)的主动脉输入阻抗降低,过渡频率范围(从0.1至2 Hz)向左移动,而高频范围(高于2 Hz)保持不变。使用三元风箱模型对主动脉输入阻抗进行参数化表明,E - 1020(静脉注射剂量为100微克/千克)使动脉阻力降低35%(p小于0.01),动脉顺应性增加12%(p小于0.01)。得出的结论是,E - 1020除了具有强心作用外,还通过减轻静态和动态后负荷来改善心脏功能。

相似文献

1
Effects of the new cardiotonic phosphodiesterase inhibitor 1,2-dihydro-5- imidazo[1,2-a]pyridin-6-yl-6-methyl-2-oxo-3-pyridine-carbonitrile hydrochloride monohydrate on aortic input impedance.新型强心磷酸二酯酶抑制剂1,2 - 二氢 - 5 - 咪唑并[1,2 - a]吡啶 - 6 - 基 - 6 - 甲基 - 2 - 氧代 - 3 - 吡啶甲腈盐酸盐一水合物对主动脉输入阻抗的影响
Arzneimittelforschung. 1991 Dec;41(12):1211-5.
2
Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Arzneimittelforschung. 1989 Jan;39(1):38-45.
3
Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 1st communication: studies on isolated guinea pig cardiac muscles.新型强心剂盐酸一水合 1,2 - 二氢 - 6 - 甲基 - 2 - 氧代 - 5 -(咪唑并[1,2 - a]吡啶 - 6 - 基)- 3 - 吡啶甲腈的心血管效应。首次通讯:对豚鼠离体心肌的研究
Arzneimittelforschung. 1989 Jan;39(1):33-7.
4
The effect of extraanatomic bypass on aortic input impedance studied in open chest dogs. Should the vascular prosthesis be compliant to unload the left ventricle?在开胸犬中研究解剖外旁路对主动脉输入阻抗的影响。血管假体是否应具有顺应性以减轻左心室负荷?
J Thorac Cardiovasc Surg. 1991 Nov;102(5):774-83.
5
Imidazo[1,2-a]pyridines. I. Synthesis and inotropic activity of new 5-imidazo[1,2-a]pyridinyl-2(1H)-pyridinone derivatives.
Chem Pharm Bull (Tokyo). 1991 Jun;39(6):1556-67. doi: 10.1248/cpb.39.1556.
6
Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
Arzneimittelforschung. 1994 Aug;44(8):948-50.
7
Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.新型磷酸二酯酶III抑制剂静脉注射R 80122对麻醉和清醒犬的心脏及血流动力学影响
Arch Int Pharmacodyn Ther. 1992 Mar-Apr;316:60-74.
8
Hemodynamic efficacy of E-1020 in comparison with dopamine on acute mitral regurgitation in anesthetized dogs.E-1020与多巴胺对麻醉犬急性二尖瓣反流血流动力学疗效的比较
Jpn Circ J. 1991 Nov;55(11):1068-76. doi: 10.1253/jcj.55.1068.
9
Effects of a new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-[imidazo (1,2-a) pyridin-6-yl]-3-pyridine carbonitrile hydrochloride monohydrate (E-1020) on contractile force and cyclic AMP metabolism in canine ventricular muscle.新型强心剂1,2 - 二氢 - 6 - 甲基 - 2 - 氧代 - 5 - [咪唑(1,2 - a)吡啶 - 6 - 基] - 3 - 吡啶甲腈盐酸盐一水合物(E - 1020)对犬心室肌收缩力及环磷酸腺苷代谢的影响
Jpn J Pharmacol. 1990 Feb;52(2):215-24. doi: 10.1254/jjp.52.215.
10
Pharmacologic and pharmacodynamic effects of the selective low Km cyclic AMP phosphodiesterase III inhibitors WIN 63291 and WIN 62582.选择性低 Km 环磷酸腺苷磷酸二酯酶 III 抑制剂 WIN 63291 和 WIN 62582 的药理及药效学作用
J Cardiovasc Pharmacol. 1994 Sep;24(3):403-10.